Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hybridoma technology: the preferred method for monoclonal antibody generation for in vivo applications.

Literature DB >> 31347924

Hybridoma technology: the preferred method for monoclonal antibody generation for in vivo applications.

Samantha Zaroff¹, Grace Tan¹.

Abstract

Keywords: models; antibodies; cancer; immunology; immunotherapy; reagents

Mesh：

Substances：

Year: 2019 PMID： 31347924 DOI： 10.2144/btn-2019-0054

Source DB: PubMed Journal: Biotechniques ISSN： 0736-6205 Impact factor: 1.993

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. AAPS Perspective on the EURL Recommendation on the use of Non-Animal-Derived Antibodies.

Authors: B Gorovits; A Hays; D Jani; C Jones; C King; A Lundequist; J Mora; M Partridge; D Pathania; S S Ramaswamy; D Rutwij; H Shen; G Starling
Journal: AAPS J Date: 2021-03-01 Impact factor: 4.009

2. A Tiered Approach for Characterization to Ensure Quality, Reproducibility, and Long-Term Stability of Critical Reagents in Regulated Bioanalysis to Support PK/ADA/NAb Assays for Biologics and Vaccines Programs.

Authors: Kun Yang; Ying Zhang; Robert Chou; Lai Yeung; Simon Letarte; Rong-Sheng Yang; Xuanwen Li; Maribel Beaumont; Rico Gunawan; Douglas Richardson; Shara Dellatore; Eric Woolf; Yang Xu
Journal: ACS Pharmacol Transl Sci Date: 2020-10-28

3. Design and Characterization of a Novel Hapten and Preparation of Monoclonal Antibody for Detecting Atrazine.

Authors: Lingyuan Xu; A M Abd El-Aty; Jae-Han Shim; Jong-Bang Eun; Xingmei Lei; Jing Zhao; Xiuyuan Zhang; Xueyan Cui; Yongxin She; Fen Jin; Lufei Zheng; Jing Wang; Maojun Jin; Bruce D Hammock
Journal: Foods Date: 2022-06-13

4. Methods to Produce Monoclonal Antibodies for the Prevention and Treatment of Viral Infections.

Authors: Yu A Merkuleva; D N Shcherbakov; A A Ilyichev
Journal: Russ J Bioorg Chem Date: 2022-05-26 Impact factor: 1.254

Review 5. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.

Authors: Hilal Ahmed Parray; Shivangi Shukla; Sweety Samal; Tripti Shrivastava; Shubbir Ahmed; Chandresh Sharma; Rajesh Kumar
Journal: Int Immunopharmacol Date: 2020-05-27 Impact factor: 4.932

10. The UK Veterinary Immunological Toolbox Website: promoting vaccine research by facilitating communication and removing reagent barriers.

Authors: William Mwangi; Giuseppe Maccari; Jayne C Hope; Gary Entrican; John A Hammond
Journal: Immunology Date: 2020-07-29 Impact factor: 7.397

Hybridoma technology: the preferred method for monoclonal antibody generation for in vivo applications.

1. AAPS Perspective on the EURL Recommendation on the use of Non-Animal-Derived Antibodies.

2. A Tiered Approach for Characterization to Ensure Quality, Reproducibility, and Long-Term Stability of Critical Reagents in Regulated Bioanalysis to Support PK/ADA/NAb Assays for Biologics and Vaccines Programs.

3. Design and Characterization of a Novel Hapten and Preparation of Monoclonal Antibody for Detecting Atrazine.

4. Methods to Produce Monoclonal Antibodies for the Prevention and Treatment of Viral Infections.

Review 5. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.

6. Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review).

Review 7. Hybridoma technology; advancements, clinical significance, and future aspects.

8. A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain.

Review 9. Antibodies, Nanobodies, or Aptamers-Which Is Best for Deciphering the Proteomes of Non-Model Species?

10. The UK Veterinary Immunological Toolbox Website: promoting vaccine research by facilitating communication and removing reagent barriers.